Senior Director, M&A and BD&L

At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits. This is work that transforms the lives of patients, and the careers of those who do it.

Summary   The Senior Director, M&A and BD&L will report to the Executive Director, M&A and BD&L and be a member of the organization responsible for executing external transactions to grow and complement BMS’ R&D portfolio. The individual will be responsible for structuring, negotiating and executing a variety of transaction types, including mergers & acquisitions, research collaborations, licensing, externalizations (out-licensing, spin-outs), divestitures and equity investments.   This is a senior individual contributor role within the M&A and BD&L function, and the individual will be a key member of the M&A and BD&L team, working closely with the Leadership Team to support the function's overall performance. The Senior Director will manage their assigned work, lead the execution of significant transactions, and serve as a trusted representative of BMS in negotiations, internal governance, and strategic discussions. The Senior Director is expected to provide strong peer leadership across the team and may mentor more junior colleagues; direct people management experience is not required for this role but is considered a plus.

Lead (including structuring and negotiating) significant transactions on behalf of BMS, including M&A, licensing, and divestitures, under the guidance of the Executive Director; Drive the deal process from first contact with potential partners to execution of definitive agreements   Support the M&A and BD&L Leadership team in managing the pipeline of M&A BD&L opportunities, contributing insights and analysis to inform strategic priorities, in partnership with R&D and Commercial colleagues   Lead valuation, financial, and strategic analyses for assigned transactions, ensuring rigor and consistency in decision-making   Partner with therapeutic area leads and other key personnel to define and execute strategies for acquiring/licensing external assets   Serve as a skilled negotiator on assigned transactions, representing BMS's interests with rigor and professionalism   Presents business rationale, analyses and proposals to senior stakeholders and supports the governance and approval process for assigned transactions end-to-end   Build and maintain strong external relationships, including with investment banks, law firms, and target or partner company leadership   Serve as a trusted advisor and thought partner to the Executive Director s and SVP , M&A and BD&L on assigned transactions and strategic priorities   Provide peer leadership and mentorship to junior members of the M&A and BD&L team; direct management of a team is not required but is a plus   Core Capabilities & Experience Desired   Bachelor's degree required; MBA, JD, PhD or other advanced business or science degree very strongly preferred   12 years of relevant experience in biotech or pharmaceutical companies, including a strong track record of identifying, evaluating, and executing transactions; Must have significant experience in M&A and BD&L, investment banking, or corporate development   Financial Acumen:   Highly skilled in financial analysis, valuation, and structuring deals; contributes to rigor and consistency in financial decision-making across the function   Negotiations & Contracting Proficiency:   A skilled negotiator with a strong track record leading and closing complex transactions   Business Judgement:   Skilled at solving